Danaher

Danaher

Yahoo Finance • 5 hours ago

Danaher (DHR) Wins FDA Clearance For Hemorrhagic Fever Test With Four Virus Detection

Danaher (NYSE:DHR) unit Cepheid has received FDA clearance for its Xpert Hemorrhagic Fever Panel multiplex PCR test. The assay can simultaneously detect Ebola, Marburg, Lassa, and Crimean Congo hemorrhagic fever viruses from a single patie... Full story

Yahoo Finance • 7 hours ago

Downstream Processing - Global Strategic Business Report 2026: Capitalize on 15.7% CAGR to US$128.9 Billion by 2032 as Danaher, Merck, Sartorius, and Thermo Fisher Reshape Biomanufacturing

Company Logo Boost ROI with automation, single-use systems, continuous processing and real-time analytics that reduce costs, accelerate purification, and improve yield and product quality. Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Downs... Full story

Yahoo Finance • 8 hours ago

Glycomics / Glycobiology - Global Strategic Business Report 2026: Capitalize on a $4.5 Billion Market by 2032 | Agilent, Bruker, Danaher, Merck, and Thermo Fisher Battle for Share

Company Logo Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Glycomics / Glycobiology - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global glycomics / glycobiology market was valued at US$1.... Full story

Yahoo Finance • 12 hours ago

Danaher (DHR), Why Is It Drawing Fresh Attention Today?

Danaher (DHR) is back in focus after U.S. regulators cleared the Access MeMed BV assay, a rapid test that helps clinicians distinguish bacterial from viral infections and potentially curb unnecessary antibiotic use. That regulatory win co... Full story

Yahoo Finance • 2 days ago

Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption

Company Logo R&D investment, CRISPR, NGS, personalized medicine and diagnostics drive demand, while strategic partnerships accelerate reagent innovation and commercialization. Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Biotechnology Reag... Full story

Yahoo Finance • 6 days ago

AI in Pathology Market Size, Share, Trends, and Global Forecast 2026-2036 | A $1.72 Billion Opportunity Featuring Profiles of Key Players Leica Biosystems (Danaher), Roche, Hamamatsu Photonics, Fujifilm, Agilent Technologies

Company Logo Boost ROI by targeting services, computer vision, drug discovery, diagnostic labs and Asia-Pacific, supported by cloud integration and strategic partnerships Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "AI in Pathology Market... Full story

Yahoo Finance • 6 days ago

Molecular Spectroscopy - Global Strategic Business Report: Capitalize on the Surge to $8.7 Billion by 2032 as Agilent, Bruker, Danaher, and Thermo Fisher Scientific Accelerate AI-Driven Analysis

Company Logo Boost ROI by targeting pharma, portable and AI-enabled spectroscopy, rapid testing, regulatory compliance, and Asia-Pacific expansion. Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Molecular Spectroscopy - Global Strategic Busi... Full story

Yahoo Finance • 6 days ago

Global Pooled CRISPR Screening Market Report 2026 | Capitalize on 16.1% CAGR as Thermo Fisher, Merck, Danaher and Agilent Accelerate AI-Driven Multi-Omics Workflows

Company Logo Players: Thermo Fisher, Merck KGaA, Danaher, Agilent and QIAGEN. Profile covers CRISPR screening segments, trends, competition, regions and opportunities. Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Pooled Clustered Regularly... Full story

Yahoo Finance • 8 days ago

BIO (BIO) vs. TMO and DHR: Can Activist Pressure Close Bio-Rad’s Valuation Discount?

Is BIO a good stock to buy? We came across a bullish thesis on Bio-Rad Laboratories, Inc. on One Idea Per Day's Substack by Paul. The thesis was published on July 21st, when the stock was trading at $281.11, and BIO has gained 32.48% since... Full story

Yahoo Finance • 13 days ago

GE HealthCare Technologies (GEHC) vs. DHR and MDT: Can a $23.9B Backlog and AI Innovation Drive a Healthcare Re-Rating?

Is GEHC a good stock to buy? We came across a bullish thesis on GE HealthCare Technologies Inc. on Astute Optics - US's Substack. The thesis was published on September 13th, when the stock was trading at $64.25, and GEHC gained 9.30% since... Full story

Yahoo Finance • 14 days ago

Danaher (DHR) Stock Fair Value Edges Higher After Analysts Lift Targets

Danaher is back in focus as analysts edge price targets into the US$240 to US$255 range, with some models now centering around fair value of about US$244.14. This shift reflects recent research that is divided between optimism on improving... Full story

Yahoo Finance • 14 days ago

Sector Update: Healthcare Stocks Decline Wednesday Afternoon

Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index down 0.7% and the Sta PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 14 days ago

Abbott to Separate Nutrition Business as Quarterly Results, Along With Thermo Fisher, Danaher Rise Annually

Abbott Laboratories (ABT) disclosed plans on Wednesday to separate its nutrition business into a pub PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 14 days ago

Strong Price Rally Validates Danaher’s (DHR) Undervalued Entry Point in Core Diagnostics Engine

L1 Capital, an investment management firm, released its "L1 Capital International Fund" (unhedged) third-quarter 2026 investor letter. A copy of the letter can be downloaded here. This Quarterly Report covers the unusually complex investme... Full story

Yahoo Finance • 14 days ago

Stocks making the biggest moves premarket: SpaceX, Super Micro Computer, Netflix, Dell and more

Check out the companies making the biggest moves premarket: Intuitive Surgical — The medical robotics stock slid 6% as the company's third-quarter results failed to impress investors. Intuitive Surgical earned $3 per share, excluding certa... Full story

Yahoo Finance • 14 days ago

Stocks Rise Pre-Bell as Traders Await Meta, Tesla Earnings

The main US stock measures were moving higher in Wednesday's premarket activity as traders await the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 15 days ago

Healthcare and Life Sciences Leaders Build on NVIDIA to Advance Drug Discovery and Expand Patient Care

NVIDIA Healthcare and Life Sciences Leader Build on NVIDIANVIDIA today announced collaborations with leading global healthcare and research organizations to advance protein design — including through a newly released open model, RFD4-Prot... Full story

Yahoo Finance • 15 days ago

Global Bioprocessing Reagent Market Report 2026 | Capitalize on 12.3% CAGR as Thermo Fisher, Danaher, Merck KGaA and Sartorius Accelerate AI and Single-Use Systems

Company Logo Boost ROI via single-use systems, AI optimization and continuous processing to cut capital costs, contamination and downtime while improving yield, scalability and efficiency. Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Biopr... Full story

Yahoo Finance • 15 days ago

Upstream Bioprocessing Equipment Market Report 2026: Forecast to 2030 | Accelerate Single-Use Scale-Up as Thermo Fisher, Merck, Danaher, Sartorius and Repligen Drive 10.9% CAGR

Company Logo Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Upstream Bioprocessing Equipment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global upstream bioprocessing equipment market is projected to grow rap... Full story

Yahoo Finance • 15 days ago

Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry

Company Logo Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Bioconjugation Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global bioconjugation market is experiencing rapid growth, supported by expanding biologi... Full story